Pfizer hopes for October vaccine OK as US orders 100M doses; CDC director ‘absolutely’ wants grandkids back in school
The U.S. government has placed an initial order for 100 million doses of a vaccine candidate being developed by Pfizer and a German firm, BioNTech, for $1.95 billion, the companies announced Wednesday.
The U.S. can acquire up to 500 million additional doses, the statement said.
Meanwhile, federal unemployment benefits are taking a hit at a time when more states are abruptly pausing their reopening plans. The $600 weekly jobless benefits bonus, approved in March, is about to expire and likely won’t be extended or replaced before next month. And a former director of the Centers for Disease Control and Prevention says states should be releasing far more data to help get a handle on the pandemic.
“We’re flying blind on the risk and effectiveness of the response,” Dr. Tom Frieden said. “Data are inconsistent, incomplete and inaccessible.”
The U.S. has been averaging more than 60,000 new cases daily for multiple